Gophers football adds Michigan State transfer Jaren Mangham via transfer portal
The Gophers football program added its third transfer running back of the offseason on Tuesday. Michigan State tailback Jaren Mangham confirmed his commitment to the U via the NCAA transfer portal.
Mangham has totaled 1,332 yards on 344 carries (3.8 yards per carry) over five collegiate seasons — 2023 with Michigan State, 2021-21 with South Florida and 2019-20 with Colorado. He also has 27 career receptions for 162 yards. He has totaled 23 touchdowns.
Last season with the Spartans, the Detroit native had 31 carries for 81 yards and seven receptions for 37 yards.
Mangham, who is listed at 6-foot-2 and 231 pounds, joins Sieh Bangura (Ohio) and Marcus Major (Oklahoma) as new additions to the Gophers since the end of the 2023 season. Mangham, 24, has one final season of eligibility for the Gophers.
Sophomore Darius Taylor figures to receive the majority of the carries next fall, but another option has joined the U running back room.
Related Articles
Will Gophers get a second chance with former top in-state recruit Jaxon Howard?
Gophers happy to get out of town as they head to Sioux Falls for NCAA tournament
More Stories
Meta and TikTok fail to halt thousands of social media addiction lawsuits
A US appeals court has rejected a challenge by Meta and TikTok, allowing wider litigation against major platforms to proceed...
Harrods returns to £84.9m profit after Al Fayed compensation payouts
Harrods returned to a pre-tax profit of £84.9 million in the year to the end of January, according to its...
Beyoncé buys out LVMH’s stake in SirDavis whisky brand
Beyoncé has acquired full control of SirDavis, the American whisky brand she established two years ago with LVMH, after the...
87% of parents want entrepreneurial skills taught in schools
More than a third of British parents (35 per cent) would rather their child start a business than go to...
Cambridge Aerospace valued at $3.4bn after raising $300m
Defence technology company Cambridge Aerospace has raised $300 million at a valuation of $3.4 billion, two years after it was...
Rare disease investment rises after US voucher renewal, UK lags
Investment in rare disease biotechs has increased since the US Food and Drug Administration’s Rare Pediatric Disease Priority Review Voucher...
